Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer’s Disease Undergoing Cholinesterase Inhibitor Treatment

OBJECTIVES: Cholinesterase inhibitors (ChEIs) are the mainstream treatment for delaying cognitive decline in Alzheimer’s disease (AD). Low vitamin B12 is associated with cognitive dysfunction, and its supplementation has been applied as the treatment for certain types of reversible dementia. The pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hsiao Shan, Huang, Li Kai, Lee, Yao Tung, Chan, Lung, Hong, Chien Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954104/
https://www.ncbi.nlm.nih.gov/pubmed/29867734
http://dx.doi.org/10.3389/fneur.2018.00325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954104/
https://www.ncbi.nlm.nih.gov/pubmed/29867734
http://dx.doi.org/10.3389/fneur.2018.00325

Ejemplares similares